-
Precautions for emptying and adding liquid of the integrated medical high and low temperature cooling machine
Time of Update: 2022-04-27
When adding liquid to the integrated medical high and low temperature cooling machine, pay attention to open the cover counterclockwise, insert the funnel to inject the heat transfer medium, so that the liquid fills the expansion liquid surface; 6.
-
The weather vane Roche "broken down", and the TIGIT target of the rising star hangs?
Time of Update: 2022-04-27
On March 30, Genentech, a subsidiary of Roche Group, said that TIGIT monoclonal antibody Tiragolumab in combination with PD-L1 failed as a first-line therapy for the treatment of extensive-stage small cell lung cancer .
-
The global CRO landscape has changed dramatically!
Time of Update: 2022-04-27
Looking at the development history of the CRO industry, whether it is LabCorp and IQVIA, whose revenue exceeds 10 billion US dollars, which is unmatched, or the local CRO leader WuXi PharmaTech, whose business revenue has increased by 38.
-
Counterfeit HIV drug ravages DOJ probe into Gilead, GSK, J&J-related drugs
Time of Update: 2022-04-27
Recently, as counterfeit drugs against AIDS (HIV) drugs such as Biktarvy, Descovy and Symtuza are rampant, the US Department of Justice has launched an investigation into counterfeit drugs from Gilead, GlaxoSmithKline and Johnson & Johnson, and strives to clear the circulation system of patients' health and treatment.
-
FDA grants priority review to futibatinib, FGFR inhibitor tripartite situation may be broken
Time of Update: 2022-04-27
In April 2021, futibatinib was granted Breakthrough Drug Designation by the FDA for the treatment of patients with previously treated locally advanced or metastatic cholangiocarcinoma harboring FGFR2 gene rearrangements .
-
Personnel changes in March. The executives of multinational pharmaceutical companies/local pharmaceutical companies exchanged, involving Baiji, Pfizer, Junshi...
Time of Update: 2022-04-27
On March 29, 2022, Hainan Haiyao announced that Pan Dazhong applied for his resignation as the company's director, chairman, convener of the strategy committee of the board of directors and member of the nomination committee due to retirement reasons .
-
[Global Pharmaceutical Research] In February 2022, CDE accepted 691 registrations, and continued to expand the capacity of point-to-face combination
Time of Update: 2022-04-27
In February 2022, the National Center for Drug Evaluation (CDE) accepted a total of 691 new registration applications (according to the acceptance number, excluding one-time import applications), including 492 chemical drugs, 107 biological products, and 92 traditional Chinese medicines .
-
"China's innovative drug engine" received a slap in the face
Time of Update: 2022-04-27
On March 17 this year, when the first batch of Pfizer's new crown special drug Paxlovid was released from Waigaoqiao to enter the customs, I wonder how Zhangjiang Pharmaceutical people felt?
-
Daily maintenance of automatic nucleic acid detection reagent filling machine
Time of Update: 2022-04-27
2. In the process of using the automatic nucleic acid detection reagent filling machine, the operator should pay attention to regularly observe the use of the equipment.
-
Express more than 6 billion US dollars to develop IgM antibody therapy, Sanofi reached a cooperation
Time of Update: 2022-04-27
The press release states that the collaboration aims to develop a new potential therapeutic modality that exploits the multivalent nature of IgM to create agonists that better activate cell surface receptors .
-
What parameters do you need to know about the closed high and low temperature cooling integrated machine?
Time of Update: 2022-04-27
It is necessary to pay attention to how much temperature and how long the materials in the reaction kettle need to be heated to the required temperature, so as to reduce unnecessary power consumption as much as possible .
-
What is the outlook for the biosimilar market in the next decade?
Time of Update: 2022-04-27
Countries with exception acceptance, policy incentives, and price differences are not willing to adopt a unilateral or multi-party bidding system The key driver for the development of the biosimilar market in the next decade will be the number of original products whose patents have expired during the same period .
-
Novavax applies to the EU to expand the scope of the new crown vaccine authorization for adolescents aged 12-17
Time of Update: 2022-04-27
Novavax has announced that it has submitted a Conditional Marketing Authorization Application (CMA) in the European Union for its COVID-19 vaccine Nuvaxovid (NVX-CoV2373) for adolescents aged 12-17 .
-
Structural features of rotary tablet press
Time of Update: 2022-04-27
The upper half of the machine is a tableting structure: it is mainly composed of three parts: upper punch, middle die and lower punch, and the surrounding 19 punches are evenly arranged in the The edge of the turntable and the tail of the upper and lower punches are embedded on the fixed curved guide rails.
-
What should be paid attention to when using the pharmaceutical heating and refrigeration cycle system
Time of Update: 2022-04-27
Due to the partial load of the equipment and the single-phase control system, connecting the wrong zero line will cause the equipment to not work and be damaged .
The wrong connection of the neutral and ground wires will cause the equipment to work abnormally .
-
Working principle and characteristics of turbo pulverizer
Time of Update: 2022-04-27
The characteristics of the turbo pulverizer: Strong pulverizing capacity, low energy consumption, relatively small product fineness, and large pulverizing space; the high wind pressure generated when the turbine is running can not only improve the production capacity, reduce the phenomenon of over-pulverization, but also effectively Avoid the deposition and blockage of the screen due to the material in the crushing process .
-
Today, Ruike Bio will be officially listed on the Hong Kong Stock Exchange!
Time of Update: 2022-04-27
A product pipeline of 12 innovative vaccines under development has been established, covering diseases such as cervical cancer, new coronary pneumonia, tuberculosis, herpes zoster, hand, foot and mouth disease and influenza According to the prospectus, Ruike Biotech has previously completed multiple rounds of financing.
-
Is the global new crown vaccine turning from insufficient supply to surplus?
Time of Update: 2022-04-27
Pfizer, which was also popular last year for vaccines, also said in February this year that it expected sales of the new crown vaccine Comirnaty to fall to $32 billion in 2022 .
-
Matters needing attention in the operation of small nucleic acid detection reagent filling machine
Time of Update: 2022-04-27
Screw cap, three-claw pneumatic screw cap, stable operation, reasonable design, made of SUS304 and 316L stainless steel, fully meet the requirements of the new version of GMP, is a reagent filling equipment for pharmaceutical industry, hospital preparations .
During the operation of the liquid filling machine, special attention should be paid to the following items: 1.
-
Over 3 billion!
Time of Update: 2022-04-27
Currently, 18 innovative drugs (15 category 1 new drugs) are in the approved clinical stage and above, and 4 innovative drugs are expected to be launched; , 17 varieties have been reviewed (6 first), 5 are planned to be included in the seventh batch of centralized procurement, and the first imitation of $9.
